John Ransom
Stock Analyst at Raymond James
(4.63)
# 187
Out of 5,114 analysts
205
Total ratings
66.49%
Success rate
16.19%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $14.41 | +108.19% | 10 | Oct 3, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $76.68 | -2.19% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $9.09 | -0.99% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $78.19 | +15.10% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $196.33 | +1.87% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $271.89 | +41.60% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $327.42 | +64.93% | 13 | Apr 21, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $472.98 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.26 | - | 8 | Nov 22, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $2.77 | +261.01% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $106.39 | -10.71% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $259.40 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.90 | +34.23% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $16.55 | +81.27% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $20.42 | -41.23% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $77.72 | +9.37% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $112.82 | -6.93% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $2.19 | +356.62% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.35 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $38.00 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $23.94 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $115.20 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.70 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $14.41
Upside: +108.19%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $76.68
Upside: -2.19%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $9.09
Upside: -0.99%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $78.19
Upside: +15.10%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $196.33
Upside: +1.87%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $271.89
Upside: +41.60%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $327.42
Upside: +64.93%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $472.98
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.26
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $2.77
Upside: +261.01%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $106.39
Upside: -10.71%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $259.40
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $14.90
Upside: +34.23%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $16.55
Upside: +81.27%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $20.42
Upside: -41.23%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $77.72
Upside: +9.37%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $112.82
Upside: -6.93%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $2.19
Upside: +356.62%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.35
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $38.00
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $23.94
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $115.20
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $15.70
Upside: -